The MLL3/TP53/PIK3CA cancer driver mutations promote HIF1alpha-dependent recruitment and differentiation of pro-tumor ICOShiGITRhi Blimp-1+ effector regulatory T cells in breast tumors
M. Boutet, K. Nishitani, P. Erler, N. Couturier, Z. Zhang, E. Barbieux, E. Guillen, M. Suzuki, W. Guo, G. Lauvau
This study shows that MLL3/TP53/PIK3CA mutations in breast tumors promote immunosuppressive Treg cell differentiation via HIF1alpha, leading to tumor growth and suggesting therapeutic targets.
bioRxiv · Oct 2, 2022 · PreprintImmunology